UPDATE: Piper Sandler Upgrades Biogen (BIIB) to Overweight on Proprietary Checks, Despite Prior Concerns
Tweet Send to a Friend
(Updated - June 18, 2021 9:09 AM EDT)
Piper Sandler analyst Christopher Raymond upgraded Biogen (NASDAQ: BIIB) from Neutral ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Piper Sandler analyst Christopher Raymond upgraded Biogen (NASDAQ: BIIB) from Neutral ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
